All Articles

A new collaboration with NVIDIA moves AI from the cloud to the network edge, promising hyper-personalized experiences with unprecedented speed and privacy.

Creator platform Stan unveils Stanley, an AI Head of Content for LinkedIn that promises to turn your expertise into a powerful personal brand and revenue stream.

Vertex's tax engine is now on Oracle Marketplace, offering ERP users faster deployment, enhanced performance on OCI, and streamlined global compliance.

TrueCar is mandating deeper discounts and unprecedented data access from its dealer network. Will this bold move fix a broken system or alienate its partners?

Aldeyra Therapeutics' dry eye drug, reproxalap, was rejected by the FDA for a third time, citing inconsistent data and wiping out millions in value.

A century-old cardiology group is expanding advanced heart care in the Mid-South by partnering with Atria Health, challenging the trend of hospital buyouts.

Appdome's new DefenseOS aims to end the conflict between app security and performance, offering a dedicated execution engine for mobile defenses.

StatSocial's new Substack integration gives marketers unprecedented access to the newsletter economy's valuable, high-intent audiences. What does it mean?

A new injectable dye entering Phase 3 trials promises to make lung cancer cells glow, helping surgeons remove tumors more completely and prevent recurrence.

Federal banks are funding Quebec's massive Matawinie mine, a strategic move to power North America's EV industry and challenge global supply chains.

Consumers overcharged for generic drugs may get cash from a new $17.8M settlement. Find out if you're eligible and how this fits into a larger legal war.

A leader in oil spill response since 1960, SLICKBAR® has won two major awards, underscoring its vital role in tackling environmental emergencies.

A new SHEIN survey reveals Gen Z's multi-outfit festival craze. But as the fast-fashion giant cashes in, its strategy faces mounting ethical scrutiny.

A new Philadelphia facility from Bill Gates' TerraPower aims to increase production of a rare cancer-fighting isotope by 20-fold, breaking a major bottleneck.

Boston-based PhaseV unveils its AI Conductor, a new platform designed to automate the entire clinical trial lifecycle and accelerate FDA submissions.

Zillow partners with top brokerages to launch Preview, a new tool making 'coming soon' homes public, aiming to end the era of secret pocket listings.

Primaris REIT hires investment veteran Julian Schonfeldt to lead an aggressive growth strategy, focusing on acquisitions and unlocking value from former department store sites.

Akur8 expands into life insurance by acquiring Slope Software, signaling a major shift in the actuarial tech landscape toward unified, AI-driven platforms.

After regaining Nasdaq compliance, Incannex Healthcare is leveraging its $75M war chest to advance novel treatments for sleep apnea and anxiety.

A new device acts as a security system for your air, monitoring invisible threats like mold. But can consumer tech truly deliver on this bold promise?